CLL-1 CAR-NK Cells for Relapsed/Refractory AML

NCT06307054 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Relapsed Adult AML
Refractory AML

Interventions

DRUG: anti-CLL-1 CAR NK cells

Sponsor

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine